ZyVersa Therapeutics Inc. (ZVSA) — Financial Flexibility Index
ZyVersa Therapeutics Inc. (ZVSA) has a Financial Flexibility Index of -110.21x as of September 2025. Free cash flow of $-1.41 Billion (operating CF $-1.41 Billion minus capex $0.00) represents -110% of total liabilities ($12.77 Million). Also explore ZyVersa Therapeutics Inc. (ZVSA) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ZyVersa Therapeutics Inc. Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for ZyVersa Therapeutics Inc. across 5 annual periods. Check asset allocation strategy of ZyVersa Therapeutics Inc. to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for ZyVersa Therapeutics Inc. (2020–2024)
Year-by-year free cash flow to debt coverage for ZyVersa Therapeutics Inc.. For the full company profile including market capitalisation, see ZVSA market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.63x | $-7.56 Million | $-7.56 Million | $12.08 Million | ▲ +20.8% |
| 2023 | -0.79x | $-8.72 Million | $-8.72 Million | $11.04 Million | ▼ -199.1% |
| 2022 | -0.26x | $-4.89 Million | $-4.89 Million | $18.51 Million | ▲ +29.1% |
| 2021 | -0.37x | $-5.08 Million | $-5.08 Million | $13.63 Million | ▲ +32.6% |
| 2020 | -0.55x | $-5.11 Million | $-5.11 Million | $9.24 Million | — |